Skip to main content
Log in

Adverse Cardiovascular Events in Post-Renal Transplant Patients, a Retrospective Study of Five Hundred Cases Over Twenty-Two Years

  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Background

Renal transplant recipients (RTRs) remain at an increased risk of fatal and non-fatal cardiovascular (CV) events compared to the general population. Death is most commonly due to cardiovascular diseases.

Purpose

The primary outcome of this work is the determination of adverse CV events and their risk factors in the RTR population and their effect on mortality.

Methods

A retrospective analysis has been performed on data from 500 patients at the Cairo Kidney Center, Cairo, Egypt, who underwent kidney transplantation with a graft from a living donor. Data was collected for RTR starting from 1992 till 2014.

Results

The mean age of patients was 41.90 ± 9.67 years. 63.8% of them were males. CV complications (stable angina pectoris, acute coronary syndrome, new left ventricular hypertrophy (LVH), positive myocardial perfusion scan, elevated cardiac enzymes, and invasive coronary angiography) occurred in (22.6%, 2.4%, 49.8%, 13.6%, 1.8%, and 7.6%) of patients, respectively. Other CV complications occurred in (24.0%, 11.2%, and 40.8%), including Congestive Heart Failure (CHF), cardiomyopathy, and arrhythmias.The main causes of mortality were CV diseases, infections, cancer, surgical complications, and liver disease (19.0%, 13.4%, 1.6%, 1.4%, and 1.2%), respectively.

Conclusion

RTR are at an extremely high risk of adverse CV events. CV complications (CHF, ischemic heart diseases, LVH, and arrhythmias) are the leading causes of death in RTR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References 

  1. Abecassis M, Bartlett ST. Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008;3(2):471–80. https://doi.org/10.2215/CJN.05021107.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lentine KL, Rocca Rey LA, Kolli S, et al. Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure. Clin J Am SocNephrol. 2008;3:1090.

    Article  Google Scholar 

  3. Yeo FE, Villines TC, Bucci JR, et al. Cardiovascular risk in stage 4 and 5nephropathy. Adv Chronic Kidney Dis. 2004;11:116.

    Article  PubMed  Google Scholar 

  4. Abbott KC, Reynolds JC, Taylor AJ, et al. Hospitalized atrial fibrillation after renal transplantation in the United States. Am J Transplant. 2003;3:471–6.

    Article  PubMed  Google Scholar 

  5. Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006;82:603.

    Article  PubMed  Google Scholar 

  6. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant. 2004;4:1662.

    Article  PubMed  Google Scholar 

  7. Mccullough PA, Bouchard J, Waikar SS et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes. Karger Publishers. Contrib Nephrol. 2013;182:5–12.https://doi.org/10.1159/000349962

  8. Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant. 2015;15(Suppl 2):1–34.

    Article  PubMed  Google Scholar 

  9. Kramer A, Pippias M, Noordzij M, et al. The european renal association–european dialysis and transplant association (ERA-EDTA) registry annual report 2015: a summary. Clinicalkidney journal. 2018;11:108–22.

    Google Scholar 

  10. Fernandez-Prado R, Fernandez-Fernandez B, Ortiz A. Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men. Clin Kidney J. 2018;11:1–6.

    Article  PubMed  PubMed Central  Google Scholar 

  11. El-Ballat M, El-Sayed MA, Emam HK. Epidemiology of end stage renal disease patients on regular hemodialysis in El-Beheira governorate, Egypt. Egyptian J Hos Med. 2019;76:3618–25.

    Article  Google Scholar 

  12. Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. 2019;32:389–99.

    Article  PubMed  Google Scholar 

  13. Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am SocNephrol. 2000;11:753–9.

    Google Scholar 

  14. Glicklich D, Vohra P. Cardiovascular risk assessment before and after kidney transplantation. Cardiol Rev. 2014;22:153–62.

    Article  PubMed  Google Scholar 

  15. Crosland W, Aggarwal H, Farag A, et al. The effect of renal transplantation on left ventricular function, electrocardiography, and mechanical synchrony by gated myocardial perfusion imaging. J Nucl Cardiol. 2019;26:1962–70.

    Article  PubMed  Google Scholar 

  16. Slubowska K, Lichodziejewska B, Pruszczyk P, Szmidt J, Durlik M. Left ventricular hypertrophy in renal transplant recipients in the first year after transplantation. Transplant Proc. 2014;46(8):2719–23. https://doi.org/10.1016/j.transproceed.2014.08.019.

    Article  CAS  PubMed  Google Scholar 

  17. Alhaj E, Alhaj N, Rahman I, et al. Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail. 2013;19:E40–5.

    Article  PubMed  Google Scholar 

  18. Murkamilov IT, Sabirov IS, Fomin VV, et al. Myocardial infarction in hemodialysis patients. Int Heart Vasc Dis J. 2021;9(29):27–32.

    Google Scholar 

  19. Jardine AG, Fellström B, Logan JO, et al. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study. Am J Kidney Dis. 2005;46:529–36.

    Article  PubMed  Google Scholar 

  20. Israni A, Snyder J, Skeans M, et al. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study. Am J Transplant. 2010;10:338–53.

    Article  CAS  PubMed  Google Scholar 

  21. Didier R, Yao H, Legendre M, et al. Myocardial Infarction after Kidney Transplantation: A Risk and Specific Profile Analysis from a Nationwide French Medical Information Database. J Clin Med. 2020;9:3356.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rigatto C, Parfrey P, Foley R, et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13:1084–90.

    Article  PubMed  Google Scholar 

  23. Abbott KC, Hypolite IO, Hshieh P, et al. Hospitalized congestive heart failure after renal transplantation in the United States. Ann Epidemiol. 2002;12:115–22.

    Article  PubMed  Google Scholar 

  24. Lentine KL, Costa SP, Weir MR, et al. Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2012;60:434–80.

    Article  PubMed  Google Scholar 

  25. – Małyszko J, Musiałowska D, Tomaszuk-Kazberuk A et al. Cardiovascular disease in patients qualified to kidney transplantation. Borgis - Postępy Nauk Medycznych 9/2016; 672–676

  26. Delville M, Sabbah L, Girard D, et al. Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up. PLoS ONE. 2015;10:e0131237.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Abedini S, Holme I, Fellström B, et al. Cerebrovascular events in renal transplant recipients. Transplantation. 2009;87:112–7.

    Article  PubMed  Google Scholar 

  28. Aull-Watschinger S, Konstantin H, Demetriou D, et al. Pre-transplant predictors of cerebrovascular events after kidney transplantation. Nephrol Dial Transplant. 2008;23:1429–35.

    Article  PubMed  Google Scholar 

  29. Davidson J, Wilkinson A, Dantal J, et al. New-onsetdiabetesafter transplantation: 2003 international consensus GUIDELINES1. Transplantation. 2003;75:SS3–24.

    Article  PubMed  Google Scholar 

  30. Choudhury PS, Mukhopadhyay P, Roychowdhary A, et al. Prevalence and Predictors of “New-onset Diabetes after Transplantation” (NODAT) in Renal Transplant Recipients: An Observational Study. Indian J Endocrinol Metab. 2019;23:273–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Tsampalieros A, Knoll GA. Evaluation and management of proteinuria after kidney transplantation. Transplantation. 2015;99:2049–60.

    Article  CAS  PubMed  Google Scholar 

  32. Borrego Hinojosa J, GentilGovantes MA, Cabello Díaz M, et al. Progression of urinary protein excretion after kidney transplantation: A marker for poor long-term prognosis. Nefrologia. 2015;35:374–84.

    Article  PubMed  Google Scholar 

  33. Vella J. Kidney transplantation in adults: Patient survival after kidney transplantation. Literature review current through: Mar 2023. 2019.

  34. Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation. 2002;73:1923–8.

    Article  PubMed  Google Scholar 

  35. Awan AA, Niu J, Pan JS, et al. Trends in the causes of death among kidney transplant recipients in the United States (1996–2014). Am J Nephrol. 2018;48:472–81.

    Article  PubMed  Google Scholar 

  36. Siedlecki A, Foushee M, Curtis JJ, et al. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation. 2007;84:1610.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the word clerk team who present a lot of help in bringing and collecting all data from the filing system and old files.

Funding

No funds, grants, or other support was received.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed Soliman.

Ethics declarations

Disclosure

The authors have no competing interests to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soliman, M., Eskander, A., Effat, H. et al. Adverse Cardiovascular Events in Post-Renal Transplant Patients, a Retrospective Study of Five Hundred Cases Over Twenty-Two Years. Curr Transpl Rep 10, 89–99 (2023). https://doi.org/10.1007/s40472-023-00399-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-023-00399-0

Keywords

Navigation